Works matching DE "IRBESARTAN"

Results: 211

Acute neck swelling: A diagnostic dilemma in a regional hospital.

Published in:

2010

By:

Pedersen, Alan

Publication type:

Case Study

Lack of efficacy of m TOR inhibitors and ACE pathway inhibitors as antifibrotic agents in evolving and established fibrosis in Mdr2 −/− mice.

Published in:

Liver International, 2015, v. 35, n. 4, p. 1451, doi. 10.1111/liv.12494

By:

Bridle, Kim R.;
Sobbe, Amy L.;
Guzman, C. Erika;
Santrampurwala, Nishreen;
Jaskowski, Lesley A.;
Clouston, Andrew D.;
Campbell, Catherine M.;
Nathan Subramaniam, V.;
Crawford, Darrell HG

Publication type:

Article

Corrigendum: Irbesartan mitigates acute liver injury, oxidative stress, and apoptosis induced by acetaminophen in mice.

Published in:: Journal of Biochemical & Molecular Toxicology, 2021, v. 35, n. 6, p. 1, doi. 10.1002/jbt.22772
Publication type:: Article

Irbesartan mitigates acute liver injury, oxidative stress, and apoptosis induced by acetaminophen in mice.

Published in:

Journal of Biochemical & Molecular Toxicology, 2020, v. 34, n. 12, p. 1, doi. 10.1002/jbt.22447

By:

Helal, Manar G.;
Samra, Yara A.

Publication type:

Article

Late-Onset Anaphylaxis due to Irbesartan.

Published in:

2020

By:

BULUT, Gökten

Publication type:

Case Study

SPECTROPHOTOMETRIC DETERMINATION OF ACTIVE COMPOUNDS IN AN ANTIHYPERTENSIVE FORMULATION BY HAAR-CWT METHOD.

Published in:

Journal of Faculty of Pharmacy of Ankara University / Ankara Üniversitesi Eczacilik Fakültesi Dergisi, 2021, v. 45, n. 3, p. 535, doi. 10.33483/jfpau.986786

By:

ÜSTÜNDAĞ, Özgür;
DİNÇ, Erdal

Publication type:

Article

A validated stability-indicating liquid chromatographic method for determination of process related impurities and degradation behavior of Irbesartan in solid oral dosage.

Published in:

Journal of Advanced Pharmaceutical Technology & Research, 2014, v. 5, n. 1, p. 33, doi. 10.4103/2231-4040.126985

By:

Goswami, Nishant

Publication type:

Article

COMPARISON OF TWO ANALYTICAL METHODS FOR THE DETERMINATION OF IRBESARTAN IN PHARMACEUTICAL PRODUCTS.

Published in:

Albanian Journal of Natural & Technical Sciences, 2010, v. 27, n. 1, p. 161

By:

Gavani, Eva;
Lazo, Pranvera;
Jakaj, Besnik

Publication type:

Article

Bioequivalence study of 300 mg irbesartan film-coated tablets preparations in healthy Thai volunteers.

Published in:

Thai Journal of Pharmaceutical Sciences, 2013, v. 37, n. 4, p. 186

By:

Puranajoti, Porranee;
Werarak, Peerawong;
Intawong, Burapat;
Hongrapipat, Jarunee;
Talubsri, Rungrudee;
Sangsuriyawong, Soravee;
Kuamsuk, Temsiri

Publication type:

Article

Corrigendum to “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice”.

Published in:

2016

By:

Chen, Xiao-Wen;
Du, Xiao-Yan;
Wang, Yu-Xian;
Wang, Jian-Cheng;
Liu, Wen-Ting;
Chen, Wen-Jing;
Li, Hong-Yu;
Peng, Fen-Fen;
Xu, Zhao-Zhong;
Niu, Hong-Xin;
Long, Hai-Bo

Publication type:

Correction Notice

Stability Indicating RP-HPLC Studies for the Estimation of Irbesartan and Amlodipine Besylate in Pharmaceutical Formulations and Identification and Characterization of Degradants Using LC-MS.

Published in:

Journal of Liquid Chromatography & Related Technologies, 2015, v. 38, n. 2, p. 259, doi. 10.1080/10826076.2014.903851

By:

Bodapati, Kamala;
Vaidya, JayathirthaRao;
Siddiraju, Sridhar;
Gowrisankar, D.

Publication type:

Article

A SINGLE COMMON STABILITY INDICATING ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR ESTIMATION OF IMPURITIES IN FOUR ANGIOTENSIN II RECEPTOR BLOCKERS.

Published in:

Journal of Liquid Chromatography & Related Technologies, 2012, v. 35, n. 14, p. 1973, doi. 10.1080/10826076.2011.627615

By:

Rao, DantuDurga;
Krishna, GallaVamsi;
Reddy, A.Malleswara;
Kalyanaraman, L.;
Kyas, K.

Publication type:

Article

Rapid Stability-indicating RRLC Method for Simultaneous Estimation of Irbesartan and its Related Impurities.

Published in:

Indian Journal of Pharmaceutical Sciences, 2016, v. 78, n. 2, p. 252, doi. 10.4172/pharmaceutical-sciences.1000110

By:

RAO, K. TIRUMALA;
RAO, L. VAIKUNTA;
KANDEPI, V. V. KRISHNA MOHAN

Publication type:

Article

Systematic Approach for Trace Level Quantification of 2-N-butyl-4-spirocyclopentane-2-imidazole-5-one Genotoxic Impurity in Irbesartan Using LC-MS/MS.

Published in:

Indian Journal of Pharmaceutical Sciences, 2013, v. 75, n. 5, p. 501

By:

BHASKAR REDDY, A. VIJAYA;
VENUGOPAL, N.;
MADHAVI, G.;
MADHAVI, V.;
GANGADHARA REDDY, K.

Publication type:

Article

Angiotensin II antagonists - an assessment of their acute toxicity.

Published in:

Clinical Toxicology (15563650), 2013, v. 51, n. 5, p. 429, doi. 10.3109/15563650.2013.800875

By:

Prasa, Dagmar;
Hoffmann-Walbeck, Petra;
Barth, Susanne;
Stedtler, Uwe;
Ceschi, Alessandro;
Färber, Elke;
Genser, Dieter;
Seidel, Carola;
Deters, Michael

Publication type:

Article

The angiotensin type 2 receptor in the human adrenocortical zona glomerulosa and in aldosterone-producing adenoma: low expression and no functional role.

Published in:

Clinical Science, 2018, v. 132, n. 6, p. 627, doi. 10.1042/CS20171593

By:

Vanderriele, Paul-Emmanuel;
Caroccia, Brasilina;
Seccia, Teresa Maria;
Piazza, Maria;
Lenzini, Livia;
Torresan, Francesca;
Iacobone, Maurizio;
Unger, Thomas;
Rossi, Gian Paolo

Publication type:

Article

The first description of mucous membrane pemphigoid induced by enalapril maleate: a case report.

Published in:

BMC Oral Health, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12903-024-04865-8

By:

Xie, Yihang;
Zhang, Qiyue;
Ye, Lin;
Wang, Jiongke;
Zeng, Xin;
Zhang, Xuefeng

Publication type:

Article

Top 10 drugs 2023-24.

Published in:: Australian Prescriber, 2024, v. 47, n. 6, p. 194, doi. 10.18773/austprescr.2024.048
Publication type:: Article

Top 10 drugs 2022-23.

Published in:: Australian Prescriber, 2023, v. 46, n. 4, p. 93, doi. 10.18773/austprescr.2023.030
Publication type:: Article

Top 10 drugs 2021-22.

Published in:: Australian Prescriber, 2023, v. 46, n. 4, p. 92, doi. 10.18773/austprescr.2023.029
Publication type:: Article

Top 10 drugs 2020-21.

Published in:: Australian Prescriber, 2021, v. 44, n. 6, p. 205, doi. 10.18773/austprescr.2021.062
Publication type:: Article

Top 10 drugs 2019-20.

Published in:: Australian Prescriber, 2020, v. 43, n. 6, p. 209, doi. 10.18773/austprescr.2020.075
Publication type:: Article

Behavior of sartans (antihypertensive drugs) in wastewater treatment plants, their occurrence and risk for the aquatic environment.

Published in:

Environmental Science & Pollution Research, 2014, v. 21, n. 18, p. 10830, doi. 10.1007/s11356-014-3060-z

By:

Bayer, Anne;
Asner, Robert;
Schüssler, Walter;
Kopf, Willi;
Weiß, Klaus;
Sengl, Manfred;
Letzel, Marion

Publication type:

Article

CYP2C93 and 13 alleles significantly affect the pharmacokinetics of irbesartan in healthy Korean subjects.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 2, p. 149, doi. 10.1007/s00228-011-1098-0

By:

Choi, Chang-Ik;
Kim, Mi-Jeong;
Chung, Eun-Kyung;
Lee, Hye-In;
Jang, Choon-Gon;
Bae, Jung-Woo;
Lee, Seok-Yong

Publication type:

Article

Randomized multicentre pilot study of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: United Kingdom Heart and Renal Protection (HARP)- III—rationale, trial design and baseline data.

Published in:

Nephrology Dialysis Transplantation, 2017, v. 32, n. 12, p. 2043, doi. 10.1093/ndt/gfw321

By:

Haynes, Richard

Publication type:

Article

Irbesartan delays progression of nephropathy as measured by estimated glomerular filtration rate: post hoc analysis of the Irbesartan Diabetic Nephropathy Trial.

Published in:

Nephrology Dialysis Transplantation, 2012, v. 27, n. 6, p. 2255, doi. 10.1093/ndt/gfr696

By:

Evans, Marc;
Bain, Stephen C.;
Hogan, Simon;
Bilous, Rudy W.

Publication type:

Article

Irbesartan treatment does not influence plasma levels of the advanced glycation end products Nɛ(1-carboxymethyl)lysine and Nɛ(1-carboxyethyl)lysine in patients with type 2 diabetes and microalbuminuria. A randomized controlled trial.

Published in:

Nephrology Dialysis Transplantation, 2011, v. 26, n. 11, p. 3573, doi. 10.1093/ndt/gfr102

By:

Engelen, Lian;
Persson, Frederik;
Ferreira, Isabel;
Rossing, Peter;
Hovind, Peter;
Teerlink, Tom;
Stehouwer, Coen D.;
Parving, Hans-Henrik;
Schalkwijk, Casper G.

Publication type:

Article

The angiotensin II receptor type 2 polymorphism influences haemodynamic function and circulating RAS mediators in normotensive humans.

Published in:

Nephrology Dialysis Transplantation, 2010, v. 25, n. 12, p. 4093, doi. 10.1093/ndt/gfq564

By:

Cherney, David Z.I.;
Lai, Vesta;
Miller, Judith A.;
Scholey, James W.;
Reich, Heather N.

Publication type:

Article

Effects of angiotensin type 1 receptor blockade on arginine and ADMA synthesis and metabolic pathways in fawn-hooded hypertensive rats.

Published in:

Nephrology Dialysis Transplantation, 2010, v. 25, n. 11, p. 3518, doi. 10.1093/ndt/gfq272

By:

Chen, Gin-Fu;
Wagner, Laszlo;
Sasser, Jennifer M.;
Zharikov, Sergey;
Moningka, Natasha C.;
Baylis, Chris

Publication type:

Article

Irbesartan Attenuates Atherosclerosis in Watanabe Heritable Hyperlipidemic Rabbits: Noninvasive Imaging of Inflammation by 18F-Fluorodeoxyglucose Positron Emission Tomography.

Published in:

Molecular Imaging, 2015, v. 14, p. 1, doi. 10.2310/7290.2015.00004

By:

Yan Zhao;
Keita Fukao;
Songji Zhao;
Ayahisa Watanabe;
Tadateru Hamada;
Kazuaki Yamasaki;
Yoichi Shimizu;
Naoki Kubo;
Naoyuki Ukon;
Toru Nakano;
Nagara Tamaki;
Yuji Kuge

Publication type:

Article

Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET).

Published in:

Cardiology Research Review, 2021, n. 96, p. 3

By:

Chow C. K.

Publication type:

Article

Effects of Bailing capsule combined with irbesartan on oxidative stress, inflammatory response and immune function in patients with diabetic nephropathy.

Published in:

Journal of Hainan Medical University, 2019, v. 25, n. 9, p. 33

By:

Zhong Li;
Guang-Ming Zhang;
Sha Zheng;
Jia-Jia Zheng;
Yan Zhang;
Ping Yuan

Publication type:

Article

Voltammetric Detection of Irbesartan by Molecularly Imprinted Polymer (MIP)-Modified Screen-Printed Electrodes.

Published in:

Chemosensors, 2022, v. 10, n. 12, p. 517, doi. 10.3390/chemosensors10120517

By:

Zanoni, Camilla;
Rovida, Riccardo;
Magnaghi, Lisa Rita;
Biesuz, Raffaela;
Alberti, Giancarla

Publication type:

Article

Comparison of clinical efficacy of metoprolol combined with irbesartan and hydrochlorothiazide and non-invasive ventilator in the emergency treatment of patients with severe heart failure.

Published in:

Experimental & Therapeutic Medicine, 2018, v. 16, n. 6, p. 5059, doi. 10.3892/etm.2018.6828

By:

Zhang, Fangxia;
Zhou, Guoxia;
Guo, Lisha;
Lu, Fei;
Zhou, Guojun

Publication type:

Article

Therapeutic effect of irbesartan combined with atorvastatin calcium in the treatment of rats with coronary heart disease.

Published in:

Experimental & Therapeutic Medicine, 2018, v. 16, n. 5, p. 4119, doi. 10.3892/etm.2018.6669

By:

Li, Tao;
Yao, Weina

Publication type:

Article

Protective effect of irbesartan, an angiotensin II receptor antagonist, alone and in combination with aspirin on middle cerebral artery occlusion model of focal cerebral ischemia in rats.

Published in:

Human & Experimental Toxicology, 2011, v. 30, n. 5, p. 354, doi. 10.1177/0960327110371257

By:

Pratap, Ravi;
Pillai, K. K.;
Khanam, Razia;
Islam, Fakhrul;
Shibli Jameel Ahmad;
Akhtar, Mohammad

Publication type:

Article

How to Improve Solubility and Dissolution of Irbesartan by Fabricating Ternary Solid Dispersions: Optimization and In-Vitro Characterization.

Published in:

Pharmaceutics, 2022, v. 14, n. 11, p. 2264, doi. 10.3390/pharmaceutics14112264

By:

Akram, Aasma;
Irfan, Muhammad;
Abualsunun, Walaa A.;
Bukhary, Deena M.;
Alissa, Mohammed

Publication type:

Article

Oral Formulation Based on Irbesartan Nanocrystals Improve Drug Solubility, Absorbability, and Efficacy.

Published in:

Pharmaceutics, 2022, v. 14, n. 2, p. 387, doi. 10.3390/pharmaceutics14020387

By:

Nagai, Noriaki;
Ogata, Fumihiko;
Ike, Ayari;
Shimomae, Yurisa;
Osako, Hanano;
Nakazawa, Yosuke;
Yamamoto, Naoki;
Kawasaki, Naohito

Publication type:

Article

Understanding the Effect of Energy Density and Formulation Factors on the Printability and Characteristics of SLS Irbesartan Tablets—Application of the Decision Tree Model.

Published in:

Pharmaceutics, 2021, v. 13, n. 11, p. 1969, doi. 10.3390/pharmaceutics13111969

By:

Madžarević, Marijana;
Medarević, Đorđe;
Pavlović, Stefan;
Ivković, Branka;
Đuriš, Jelena;
Ibrić, Svetlana

Publication type:

Article

Nanocrystalline Suspensions of Irbesartan Enhance Oral Bioavailability by Improving Drug Solubility and Leading Endocytosis Uptake into the Intestine.

Published in:

Pharmaceutics, 2021, v. 13, n. 9, p. 1404, doi. 10.3390/pharmaceutics13091404

By:

Deguchi, Saori;
Ogata, Fumihiko;
Watanabe, Masaki;
Otake, Hiroko;
Yamamoto, Naoki;
Kawasaki, Naohito;
Nagai, Noriaki

Publication type:

Article

Action of irbesartan on blood pressure and glucose/lipid metabolism, in hemodialysis patients with hypertension.

Published in:

International Journal of General Medicine, 2013, v. 6, p. 405, doi. 10.2147/IJGM.S43850

By:

Akira Onishi;
Morishita, Yoshiyuk;
Minami Watanabe;
Akihiko Numata;
Mikio Tezuka;
Kosuke Okuda;
Sadao Tsunematsu;
Yasuhiro Sugaya;
Shinichi Hashimoto;
Eiji Kusano

Publication type:

Article

High doses of irbesartan offer long-term kidney protection in cases of established diabetic nephropathy.

Published in:

Nefrologia, 2012, v. 32, n. 2, p. 187, doi. 10.3265/Nefrologia.pre2011.Nov.10962

By:

Ros-Ruiz, Silvia;
Aranda-Lara, Pedro;
Fernández, Juan C.;
Martínez-Esteban, M. Dolores;
Jironda, Cristina;
Hidalgo, Pilar;
Hernández-Marrero, Domingo

Publication type:

Article

The intervention effect of zinc supplementation on irbesartan treatment for atherosclerosis of ApoE-/- mice.

Published in:

Pakistan Journal of Pharmaceutical Sciences, 2016, v. 29, n. 6, p. 1907

By:

Shuang Li;
Ke Wang;
Guofang Xu;
Jia Ji;
Chuan Qin

Publication type:

Article

Drug-drug interaction between danshensu and irbesartan and its potential mechanism.

Published in:

Xenobiotica, 2024, v. 54, n. 4, p. 211, doi. 10.1080/00498254.2024.2338183

By:

Li, Yuexia;
Liu, Liheng

Publication type:

Article

The Role of Irbesartan in the Treatment of Patients with Hypertension: A Comprehensive and Practical Review.

Published in:

High Blood Pressure & Cardiovascular Prevention, 2012, v. 19, n. 1, p. 19, doi. 10.2165/11632100-000000000-00000

By:

Borghi, Claudio;
Cicero, Arrigo F. G.

Publication type:

Article

Determination of antihypertensive drugs irbesartan and doxazosin mesylate in healthcare products and urine samples using surface-enhanced Raman scattering.

Published in:

Analytical & Bioanalytical Chemistry, 2022, v. 414, n. 27, p. 7813, doi. 10.1007/s00216-022-04315-w

By:

Ding, Yanru;
Zhang, Nan;
Zhao, Junqi;
Lv, Haiyang;
Wang, Xu;
Zhao, Bing;
Tian, Yuan

Publication type:

Article

HYDROTROPIC SOLUBILISATION OF IRBESARTAN: MECHANISTIC STUDY AND DISSOLUTION PROFILING.

Published in:

Indian Drugs, 2019, v. 56, n. 3, p. 74, doi. 10.53879/id.56.03.11612

By:

C., Jose;
K., Amra;
M., Momin

Publication type:

Article

Irbesartan protects against aluminium chloride induced amyloidogenesis and cognitive impairment.

Published in:

Journal of Krishna Institute of Medical Sciences (JKIMSU), 2022, v. 11, n. 2, p. 18

By:

Mishra, Sunita;
Prusty, Shakti Ketan;
Sahu, Pratap Kumar;
Das, Debajyoti

Publication type:

Article

Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3‐deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub‐study.

Published in:

Diabetic Medicine, 2021, v. 38, n. 9, p. 1, doi. 10.1111/dme.14405

By:

Piazza, M.;
Hanssen, N. M. J.;
Persson, F.;
Scheijen, J. L.;
van de Waarenburg, M. P. H.;
van Greevenbroek, M. M. J.;
Rossing, P.;
Hovind, P.;
Stehouwer, C. D. A.;
Parving, H‐H.;
Schalkwijk, C. G.

Publication type:

Article

Efficacy and Safety of a Fixed Combination of Irbesartan/Hydrochlorothiazide in Chinese Patients with Moderate to Severe Hypertension.

Published in:

Drugs in R&D, 2013, v. 13, n. 2, p. 109, doi. 10.1007/s40268-013-0013-9

By:

Huang, Qi-Fang;
Sheng, Chang-Sheng;
Li, Yan;
Ma, Gen-Shan;
Dai, Qiu-Yan;
Wang, Ji-Guang

Publication type:

Article